Marcos Mendes Gabriel - Dec 1, 2024 Form 3 Insider Report for MCCORMICK & CO INC (MKC)

Role
Executive VP & CFO
Signature
Jason E. Wynn, Attorney-in-Fact
Stock symbol
MKC
Transactions as of
Dec 1, 2024
Transactions value $
$0
Form type
3
Date filed
12/4/2024, 02:36 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MKC Common Stock - Voting 7.36K Dec 1, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MKC Options - Right to Buy Dec 1, 2024 Common Stock - Voting 1.09K $73.70 Direct F1
holding MKC Options - Right to Buy Dec 1, 2024 Common Stock - Voting 2.26K $69.31 Direct F1
holding MKC Options - Right to Buy Dec 1, 2024 Common Stock - Voting 3.06K $89.16 Direct F1
holding MKC Options - Right to Buy Dec 1, 2024 Common Stock - Voting 2.54K $97.26 Direct F1
holding MKC Options - Right to Buy Dec 1, 2024 Common Stock - Voting 2.91K $81.79 Direct F1
holding MKC Options - Right to Buy Dec 1, 2024 Common Stock - Voting 7.33K $76.03 Direct F1
holding MKC Options - Right to Buy Dec 1, 2024 Common Stock - Voting 24K $93.49 Direct F2
holding MKC Restricted Stock Units Dec 1, 2024 Common Stock - Voting 200 $0.00 Direct F3
holding MKC Restricted Stock Units Dec 1, 2024 Common Stock - Voting 480 $0.00 Direct F4
holding MKC Restricted Stock Units Dec 1, 2024 Common Stock - Voting 1.89K $0.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option grant becomes exercisable in thirds of each of the first three (3) grant anniversaries.
F2 The option grant vests after the third anniversary date and is only exercisable if certain stock price performance requirements are met. The performance requirements are an increase in the common stock non-voting price of 60% for 1/3 of the options, an increase in the common stock non-voting price of 80% for 1/3 of the options, and an increase in the common stock non-voting price of 100% for 1/3 of the options, in each case within five years of the grant date. Both the vesting date and performance requirements must be met for the portion of the grant to become exercisable.
F3 The Restricted Stock Units vest in thirds over a three-year period beginning March 15, 2023, March 15, 2024 and March 15, 2025.
F4 The Restricted Stock Units vest in thirds over a three-year period beginning March 15, 2024, March 15, 2025 and March 15, 2026.
F5 The Restricted Stock Units vest in thirds over a three-year period beginning March 15, 2025, March 15, 2026 and March 15, 2027.